Press room

February 5, 2025. A study published in the American Journal of Respiratory and Critical Care Medicine, in collaboration with I3PT, highlights critical gaps in the detection and management of sepsis in European hospitals

February 3, 2025. The CEIm of Parc Taulí is consolidated as the first in Catalonia and the third in Spain in the evaluation of clinical trials, according to the ranking prepared annually by the AEMPS

December 9, 2024. This is a unique treatment strategy in the healthcare field, based on non-invasive electrical stimulation to maintain the strength of the respiratory muscles of patients in need of mechanical ventilation support.

September 25, 2024. The European project team will design and implement at the Parc Taulí University Hospital an innovative and unique wastewater treatment system in Spain

Jul 25, 2024. Dubbed Optimal XR, this tool aims to prevent potentially malignant lung nodules that are currently not diagnosed in time from continuing to go unnoticed.

9 May 2024. The study, led by researchers Marta Moraleda and Débora Itzep, will investigate sleep and circadian rhythm disorders in children and adolescents with this pathology.

April 24, 2024. A study led by the I3PT finds that not following a restrictive diet does not affect quality or efficiency parameters, and improves tolerability and patient satisfaction.

February 12, 2024. The Phase IIa study will evaluate the effectiveness of CTH120 as a breakthrough therapy in adult patients with SXF, the most common form of inherited intellectual disability without a specific treatment.

8 June 2023. 5% of children under the age of 7 in Spain have asthma, and 14% have allergies, mainly allergic rhinitis.

March 20, 2023. The Institute has received this recognition of excellence from the Ministerio de Ciencia e Innovación, after successfully passing the audit process of the Instituto de Salud Carlos III.

January 18, 2023. The Secretary of Business and Competitiveness and CEO of ACCIÓ, Albert Castellanos, visited this morning the Parc Taulí University Hospital in Sabadell, where the company has carried out a pilot test of the technology.

January 4, 2023. The Parc Taulí Research and Innovation Institute (I3PT) and the Hospital Clínic sign a collaboration agreement to develop innovation projects using 3D technology

November 3, 2022. The I3PT has participated in the largest international study to date to compare antiseptic skin solutions and decrease infection in open fracture surgery. The results have been published in the journal 'The Lancet'

September 23, 2022. Researchers from the I3PT, the IMIM-Hospital del Mar and the IISPV describe a biomarker in the blood of patients with type 1 diabetes that makes it possible to identify the degree of early vascular aging associated with the risk of complications in various organs

September 8, 2022. The consolidation of the Parc Taulí 3D Laboratory as its own space for the design and manufacture of customized instruments and implants allows the establishment of this platform that will market its services on a global scale

July 25, 2022 Study results show efficacy of new treatment combining two immunotherapy drugs in patients with metastatic lung cancer

June 27, 2022. The current results of the study are very hopeful and pave the way to making a change in surgical strategy in the treatment of these tumors, which would involve performing a local chemo-radiotherapy treatment and a minimal local surgery, preserving the rectum

April 1, 2022. The initiative is part of the community health axis of the Biotop project, promoted by the City Council and the water company

January 17, 2022. ANAIS Medical is the new spin-off of the Institute that was born with the aim of developing practical educational material, through realistic models and simulators, to train and improve the skills of clinical experts in interventional processes

December 20, 2021. The scientific discovery of I3PT is part of the pioneering study published by the journal Scientific Reports, which shows that with a blood test at the time of admission of a patient with bilateral pneumonia its evolution can be anticipated

February 9, 2022. People with schizophrenia who participate in clinical trials may not be representative of the population that suffers from this disease.